Search results
Results from the WOW.Com Content Network
Ureterovesicular junction obstruction (UVJ obstruction) is an obstruction at the level of the ureter and bladder. It accounts for 20% of cases of hydronephrosis detected in utero. It is also most commonly seen in males and involved both sides of the urinary tract in approximately 25% of cases.
Treatment, depending on cause, may require prompt drainage of the bladder via catheterization, medical instrumentation, surgery (e.g., endoscopy, lithotripsy), hormonal therapy, or a combination of these modalities. [citation needed] Treatment of the obstruction at the level of the ureter: Open surgery. Less invasive treatment: laparoscopic ...
Pyeloplasty is a type of surgical procedure performed to treat an uretero-pelvic junction obstruction if residual renal function is adequate. [1]This revision of the renal pelvis treats the obstruction by excising the stenotic area of the renal pelvis or uretero-pelvic junction and creating a more capacious conduit using the tissue of the remaining ureter and renal pelvis.
Common causes of upper tract obstruction include obstructing stones and ureteropelvic junction (UPJ) obstruction caused by intrinsic narrowing of the ureters or an overlying vessel. Obstruction occurring in the lower urinary tract can also cause this increased pressure through the reflux of urine into the kidney.
The ureteric balloon catheter is intended to cure two major types of diseases: Ureteropelvic junction obstruction (also called UPJ obstruction or Pelvic-ureteric junction obstruction PUJO) [1] caused by intrinsic wall factors as fibrosis and / or hypertrophic wall problems.
After the cancer is staged, treatment may involve open surgery to remove the affected ureter and kidney if it is involved; or, if the lesion is small, it may be removed via ureteroscopy. [18] Prognosis can vary markedly depending on the tumour grade, with a worse prognosis associated with an ulcerating lesion. [18]
For women, there is a 20.5% risk for having a surgical intervention related to stress urinary incontinence. The literature suggests that white women are at increased risk for stress urinary incontinence. [12] Though pelvic floor dysfunction is thought to more commonly affect women, 16% of men have been identified with pelvic floor dysfunction. [13]
A urethral bulking injection is one type of treatment for incontinence in women. Urethral bulking injections are considered by a clinician when the woman has urinary sphincter dysfunction, urethral hypermobility, persistent stress urinary incontinence after a urethral sling or urethropexy, or stress urinary incontinence in women who cannot undergo surgery due to other illnesses or conditions.